About James Leech
James Leech is a chief financial and strategy officer at GT Medical Technologies.
Form D filings also name James Leech as an executive officer at Moximed.
James Leech first appears on SEC filings in 2024.
Experience
This experience comes from James Leech's profile and from SEC filings. For roles taken from filings, the years are when the filings name James Leech in the role, so the role may have started earlier or lasted longer.
GT Medical Technologies, Inc. Current
Chief Financial & Strategy Officer
2025 – Present · Tempe, AZ
Makes radiation implants for patients undergoing brain tumor surgery.
AM
Akeeko Medical® Current
Corporate Advisory Board
2025 – Present
SU
SutureTech Current
Corporate Advisory Board
2024 – Present
WC
Warren Point Capital Current
Managing Partner
2020 – Present
PS
Palette Life Sciences
Chief Business Officer
2019 – 2024
BA
Back Bay Life Science Advisors
Senior Associate - M&A
2014 – 2019
JL
JSB-Partners, LP
Investment Banking Analyst
2013 – 2014
PP
Provident Healthcare Partners
Investment Banking Summer Analyst
2012
Key Colleagues at Startups
The people James Leech works with at each company, as listed on that company's latest Form D.
GT Medical Technologies, Inc. · Form D, Jul 22, 2026
SA
Susana Amorim
Director
JR
Jason Rostovsky
Director
PL
Prattipati Laxminarain
Executive officer and director
Per Langoe
Chief Executive Officer and director
PE
Paul Enever
Director
KD
Kyle Dempsey
Director
David Brachman
Co-Founder and Chief Technology Officer, director
Moximed, Inc · Form D, Aug 20, 2024
DA
David Amerson
Director
JM
Joshua Makower
Director
SM
Shahzad Malik
Director
DM
David van Meter
Director
MM
Matt McAviney
Director
AC
Anton Clifford
Executive officer
MW
Michael Wasserman
Director
CG